Drugs / RhBMP-2 Protein, Recombinant
RhBMP-2 Protein, Recombinant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03396900 Comparator | Jul 2016 → Aug 2017 | malposition of teeth with or without hypodontia/oligodontia | SVS Institute of Dental Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RhBMP-2 Protein, Recombinant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03396900 ↗ |
| Modality | Protein / enzyme biologic | “Bone morphogenetic proteins (BMPs) are a category of proteins that are involved in bone formation and repair.” NCT03396900 ↗ |